Northeast Investment Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,961
| Closed | -$239K | – | 184 |
|
|
2023
Q1 | $239K | Sell |
2,961
-398
| -12% | -$32.4K | 0.01% | 164 |
|
|
2022
Q4 | $261K | Buy |
3,359
+48
| +1% | +$3.89K | 0.02% | 158 |
|
|
2022
Q3 | $267K | Sell |
3,311
-480
| -13% | -$43.1K | 0.02% | 149 |
|
|
2022
Q2 | $340K | Hold |
3,791
| – | – | 0.02% | 144 |
|
|
2022
Q1 | $421K | Buy |
3,791
+348
| +10% | +$36.8K | 0.02% | 145 |
|
|
2021
Q4 | $356K | Sell |
3,443
-273
| -7% | -$31.6K | 0.02% | 162 |
|
|
2021
Q3 | $466K | Buy |
3,716
+564
| +18% | +$73K | 0.02% | 136 |
|
|
2021
Q2 | $391K | Hold |
3,152
| – | – | 0.02% | 143 |
|
|
2021
Q1 | $372K | Sell |
3,152
-298
| -9% | -$34.9K | 0.02% | 142 |
|
|
2020
Q4 | $404K | Hold |
3,450
| – | – | 0.02% | 140 |
|
|
2020
Q3 | $359K | Sell |
3,450
-444
| -11% | -$44.6K | 0.02% | 137 |
|
|
2020
Q2 | $357K | Sell |
3,894
-590
| -13% | -$56.6K | 0.03% | 132 |
|
|
2020
Q1 | $404K | Sell |
4,484
-4,405
| -50% | -$469K | 0.04% | 112 |
|
|
2019
Q4 | $1.01M | Sell |
8,889
-16
| -0.2% | -$1.76K | 0.07% | 101 |
|
|
2019
Q3 | $967K | Buy |
8,905
+1,685
| +23% | +$176K | 0.08% | 102 |
|
|
2019
Q2 | $703K | Buy |
7,220
+760
| +12% | +$69.4K | 0.06% | 109 |
|
|
2019
Q1 | $588K | Sell |
6,460
-76
| -1% | -$6.8K | 0.05% | 111 |
|
|
2018
Q4 | $595K | Hold |
6,536
| – | – | 0.06% | 103 |
|
|
2018
Q3 | $643K | Hold |
6,536
| – | – | 0.05% | 109 |
|
|
2018
Q2 | $560K | Hold |
6,536
| – | – | 0.05% | 116 |
|
|
2018
Q1 | $524K | Hold |
6,536
| – | – | 0.05% | 112 |
|
|
2017
Q4 | $528K | Sell |
6,536
-35
| -0.5% | -$2.8K | 0.04% | 116 |
|
|
2017
Q3 | $511K | Buy |
6,571
+3,813
| +138% | +$317K | 0.05% | 117 |
|
|
2017
Q2 | $245K | Hold |
2,758
| – | – | 0.02% | 142 |
|
|
2017
Q1 | $222K | Buy |
+2,758
| New | +$215K | 0.02% | 148 |
|
|
2016
Q4 | – | Sell |
-3,034
| Closed | -$262K | – | 161 |
|
|
2016
Q3 | $262K | Buy |
3,034
+268
| +10% | +$23.4K | 0.03% | 132 |
|
|
2016
Q2 | $240K | Sell |
2,766
-3,643
| -57% | -$295K | 0.02% | 142 |
|
|
2016
Q1 | $481K | Sell |
6,409
-48
| -0.7% | -$3.62K | 0.05% | 117 |
|
|
2015
Q4 | $497K | Buy |
6,457
+19
| +0.3% | +$1.43K | 0.05% | 115 |
|
|
2015
Q3 | $431K | Buy |
6,438
+61
| +1% | +$4.49K | 0.05% | 117 |
|
|
2015
Q2 | $473K | Sell |
6,377
-510
| -7% | -$39K | 0.05% | 116 |
|
|
2015
Q1 | $537K | Buy |
6,887
+13
| +0.2% | +$985 | 0.05% | 118 |
|
|
2014
Q4 | $496K | Buy |
6,874
+32
| +0.5% | +$2.22K | 0.05% | 124 |
|
|
2014
Q3 | $424K | Buy |
6,842
+66
| +1% | +$4.2K | 0.04% | 133 |
|
|
2014
Q2 | $432K | Buy |
6,776
+2,623
| +63% | +$159K | 0.04% | 135 |
|
|
2014
Q1 | $256K | Buy |
4,153
+54
| +1% | +$3.15K | 0.03% | 159 |
|
|
2013
Q4 | $235K | Buy |
+4,099
| New | +$232K | 0.03% | 151 |
|
Other funds holding MDT
Northeast Investment Management's MDT Position: Q2 2023 in Review
Northeast Investment Management sold out of Medtronic (MDT) in Q2 2023, closing a stake of 2,961 shares — an estimated $239K sold.
Northeast Investment Management first reported a position in MDT in Q4 2013 and held it in 37 quarters. The position peaked at $1.01M in Q4 2019. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.
- Northeast Investment Management reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
- Northeast Investment Management sold 2,961 Medtronic shares in Q2 2023, an estimated $239K.
- Northeast Investment Management first reported a position in Medtronic in Q4 2013 and held it in 37 quarters.
- Northeast Investment Management's Medtronic position peaked at $1.01M in Q4 2019.
- 2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.
Based on Northeast Investment Management's 13F filing for Q2 2023, filed 28 Jul 2023.